
Real World Health, a healthcare data analytics company based in London, UK, recently announced that it has successfully raised £1.7M in Series A funding. The funding round was led by Maven Capital Partners, with additional participation from Dowgate Capital. The company plans to utilize this investment to further expand its operations and increase its business reach in the healthcare industry.
Under the leadership of CEO Scott Fletcher, Real World Health is known for providing innovative healthcare and life sciences data solutions to its clients.
One of its notable tools, Opfeed, is an elective theatre optimization tool that utilizes AI technology to convert surgeon notes into classified procedures. Additionally, the tool employs machine learning to predict the duration of each procedure and utilizes an algorithm to effectively schedule theatre bookings.
Besides physical health solutions, Real World Health also offers mental health data analytics services to secondary care providers within the NHS, including collaborations with organizations such as Central North West London and South London and Maudsley. With over 70 organizations already benefiting from its solutions in the UK, Middle East, and Australia, Real World Health continues to make significant strides in the healthcare analytics sector.
Click here for a full list of 7,526+ startup investors in the UK